Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





AI Models Can Predict Individual Risk of Hospitalization for COVID Using HIE Data

By HospiMedica International staff writers
Posted on 27 Jan 2022

A study has demonstrated how clinical data from healthcare systems can be used to better inform public health decision-making. More...

In a new study, researchers at Regenstrief Institute (Indianapolis, IN, USA) and Indiana University (Bloomington, IN, USA) demonstrated that machine learning models trained using clinical data from a statewide health information exchange can predict, on a patient level, the likelihood of hospitalization of individuals with the virus. The researchers used clinical data from 96,026 individuals from all 957 zip codes in Indiana to train decision models that predicted healthcare resource utilization.

“It has been quite challenging to bring the bread-and-butter data generated by healthcare systems together with public health decision-making - entities which have long been separate and distinct,” said study senior author Shaun Grannis, M.D., M.S., Regenstrief Institute vice president for data and analytics and professor of family medicine at Indiana University School of Medicine. “Our work shows how you can build and employ AI (artificial intelligence) models to securely utilize the clinical information in a health information exchange to support public health needs such as predicting hospital utilization within one week and within six weeks of onset of COVID infection.

“When new circumstances requiring rapid response arise, such as emergence of omicron or other new variants, once there are sufficient cases to train models, one can confidently access and plug clinical data into these readily available models to make accurate public health predictions and provide valuable insights into patient-level need for healthcare resource utilization,” said Dr. Grannis.

“Since the onset of COVID-19, researchers, healthcare systems, public health departments and others have leveraged existing data repositories and health information infrastructure for rapid analytics,” said study first author Suranga Kasturi, PhD, a Regenstrief Institute research scientist and an assistant professor of pediatrics at IU School of Medicine. “Machine learning has been invaluable in these efforts.”

“But any model is only as good as the data that goes into it,” he added. “The broad, robust data from the Indiana Network for Patient Care is representative of the US population. What we have done could be characterized as a precursor of how AI tools can be deployed across the entire country with the important caveat that whatever models are used should be evaluated for fairness across all subpopulations.”

Related Links:
Regenstrief Institute 
Indiana University 


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.